LD 1634
pg. 4
Page 3 of 9 An Act To Improve the Maine Rx Program Page 5 of 9
Download Bill Text
LR 2173
Item 1

 
D. In determining the amount of discounted prices, the
department shall consider an average of all rebates provided
pursuant to subsection 4, weighted by sales of drugs subject
to these rebates over the most recent 12-month period for
which the information is available.

 
6. Operation of program. The requirements of this subsection
apply to participating retail pharmacies.

 
A. The Maine Board of Pharmacy shall adopt rules requiring
disclosure by participating retail pharmacies to qualified
residents of the amount of savings provided as a result of
the program. The rules must consider and protect
information that is proprietary in nature. Rules adopted
pursuant to this paragraph are routine technical rules as
defined in Title 5, chapter 375, subchapter II-A 2-A.

 
B. The department may not impose transaction charges under
this program on retail pharmacies that submit claims or
receive payments under the program.

 
C. A participating retail pharmacy shall submit claims to
the department to verify the amount charged to qualified
residents under subsection 5.

 
D. On a weekly or biweekly basis, the department must
reimburse a participating retail pharmacy for the difference
between the initial discounted price and the secondary
discounted prices price provided to qualified residents
under subsection 5 and professional fees, which must be set
by the commissioner. The amount of the initial professional
fee must be set at $3 per prescription.

 
E. The department shall collect utilization data from the
participating retail pharmacies submitting claims necessary
to calculate the amount of the rebate from the manufacturer
or labeler. The department shall protect the
confidentiality of all information subject to
confidentiality protection under state or federal law, rule
or regulation.

 
F.__The department shall conduct ongoing quality assurance
activities similar to those used in the MaineCare program.

 
Sec. 5. 22 MRSA §2681, sub-§7, as enacted by PL 1999, c. 786, Pt. A,
§3 and amended by PL 2001, c. 405, §2 and affected by §3, is
repealed and the following enacted in its place:

 
7.__Action with regard to nonparticipating manufacturers and
labelers.__The names of manufacturers and labelers who do not


Page 3 of 9 Top of Page Page 5 of 9